E. Anitua, I. Andia, and B. Ardanza, Autologous platelets as a source of proteins for healing and tissue regeneration, Thrombosis and Haemostasis, vol.91, pp.4-15, 2004.
DOI : 10.1160/TH03-07-0440

J. George, Platelets, The Lancet, vol.355, issue.9214, pp.1531-1540, 2000.
DOI : 10.1016/S0140-6736(00)02175-9
URL : https://hal.archives-ouvertes.fr/hal-01455290

M. Martinez, C. Kunzelmann, and J. Freyssinet, Remodelage de la membrane plasmique et stimulation cellulaire, m??decine/sciences, vol.20, issue.2, pp.189-95, 2004.
DOI : 10.1051/medsci/2004202189

A. Weyrich and G. Zimmerman, Platelets: signaling cells in the immune continuum, Trends in Immunology, vol.25, issue.9, pp.489-95, 2004.
DOI : 10.1016/j.it.2004.07.003

W. Fanslow, S. Srinivasan, and R. Paxton, Structural characteristics of CD40 ligand that determine biological function, Seminars in Immunology, vol.6, issue.5, pp.267-78, 1994.
DOI : 10.1006/smim.1994.1035

C. Van-kooten and J. Banchereau, CD40-CD40 ligand, J Leuk Biol, vol.67, pp.2-17, 2000.

F. Chan, H. Chun, and L. Zheng, A Domain in TNF Receptors That Mediates Ligand-Independent Receptor Assembly and Signaling, Science, vol.288, issue.5475, pp.2351-2355, 2000.
DOI : 10.1126/science.288.5475.2351

C. Van-kooten and J. Banchereau, CD40-CD40 Ligand: A Multifunctional Receptor-Ligand Pair, Adv Immunol, vol.61, pp.1-77, 1996.
DOI : 10.1016/S0065-2776(08)60865-2

J. Levy, T. Espanol-boren, and C. Thomas, Clinical spectrum of X-linked hyper-IgM syndrome, The Journal of Pediatrics, vol.131, issue.1, pp.47-54, 1997.
DOI : 10.1016/S0022-3476(97)70123-9

M. Kuwana, S. Nomura, and K. Fujimura, Effect of a single injection of humanized anti-CD154 monoclonal antibody on the platelet-specific autoimmune response in patients with immune thrombocytopenic purpura, Blood, vol.103, issue.4, pp.1229-1265, 2004.
DOI : 10.1182/blood-2003-06-2167

V. Henn, J. Slupsky, and M. Grafe, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, vol.391, pp.591-595, 1998.

P. Aukrust, F. Muller, and T. Ueland, Enhanced Levels of Soluble and Membrane-Bound CD40 Ligand in Patients With Unstable Angina : Possible Reflection of T Lymphocyte and Platelet Involvement in the Pathogenesis of Acute Coronary Syndromes, Circulation, vol.100, issue.6, pp.614-634, 1999.
DOI : 10.1161/01.CIR.100.6.614

K. Otterdal, T. Pedersen, and N. Solum, Release of soluble CD40 ligand after platelet activation, Thrombosis Research, vol.114, issue.3, pp.167-77, 2004.
DOI : 10.1016/j.thromres.2004.05.007

M. Furman, L. Krueger, and M. Linden, Release of soluble CD40L from platelets is regulated by glycoprotein IIb/IIIa and actin polymerization, Journal of the American College of Cardiology, vol.43, issue.12, pp.2319-2344, 2004.
DOI : 10.1016/j.jacc.2003.12.055

A. Solanilla, J. Pasquet, and J. Viallard, Platelet-associated CD154 in immune thrombocytopenic purpura, Blood, vol.105, issue.1, pp.215-223, 2005.
DOI : 10.1182/blood-2003-07-2367
URL : https://hal.archives-ouvertes.fr/hal-00019938

F. Pietravalle, S. Lecoanet-henchoz, and H. Blasey, Human native soluble CD40L is a biologically active trimer, processed inside microsomes, J Biol Chem, vol.271, pp.5965-5972, 1996.

D. Graf, S. Muller, and U. Korthauer, A soluble form of TRAP (CD40 ligand) is rapidly released after T cell activation, European Journal of Immunology, vol.6, issue.6, pp.1749-54, 1995.
DOI : 10.1002/eji.1830250639

M. Karpusas, Y. Hsu, and J. Wang, 2 ?? crystal structure of an extracellular fragment of human CD40 ligand, Structure, vol.3, issue.10, pp.1031-1040, 1995.
DOI : 10.1016/S0969-2126(01)00239-8

A. Weber, A. Hermann, B. Rauch, and K. Schror, Molecular identity of platelet CD40 ligand (CD40L), Thromb Haemost, vol.86, p.718, 2001.

V. Henn, S. Steinbach, and K. Buchner, The inflammatory action of CD40 ligand (CD154) expressed on activated human platelets is temporally limited by coexpressed CD40, Blood, vol.98, issue.4, pp.1047-54, 2001.
DOI : 10.1182/blood.V98.4.1047

M. Moss and M. Lambert, Shedding of membrane proteins by ADAM family proteases, Essays In Biochemistry, vol.38, pp.141-53, 2002.
DOI : 10.1042/bse0380141

J. Viallard, A. Solanilla, and B. Gauthier, Increased soluble and platelet-associated CD40 ligand in essential thrombocythemia and reactive thrombocytosis, Blood, vol.99, issue.7, pp.2612-2616, 2002.
DOI : 10.1182/blood.V99.7.2612

V. Henn, J. Slupsky, and M. Grafe, CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells, Nature, vol.391, pp.591-595, 1998.

P. Andre, K. Prasad, and C. Denis, CD40L stabilizes arterial thrombi by a ??3 integrin???dependent mechanism, Nature Medicine, vol.8, issue.3, pp.247-52, 2002.
DOI : 10.1038/nm0302-247

E. Lindmark, T. Tenno, and A. Siegbahn, Role of Platelet P-Selectin and CD40 Ligand in the Induction of Monocytic Tissue Factor Expression, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.10, pp.2322-2330, 2000.
DOI : 10.1161/01.ATV.20.10.2322

J. Slupsky, M. Kalbas, and A. Willuweit, Activated platelets induce tissue factor expression on human umbilical vein endothelial cells by ligation of CD40, Thromb Haemost, vol.80, pp.1008-1022, 1998.

R. Schwabe, B. Schnabl, Y. Kweon, and D. Brenner, CD40 Activates NF-??B and c-Jun N-Terminal Kinase and Enhances Chemokine Secretion on Activated Human Hepatic Stellate Cells, The Journal of Immunology, vol.166, issue.11, pp.6812-6821, 2001.
DOI : 10.4049/jimmunol.166.11.6812

T. Tanaka, T. Kuroiwa, and H. Ikeuchi, Human Platelets Stimulate Mesangial Cells to Produce Monocyte Chemoattractant Protein-1 via the CD40/CD40 Ligand Pathway and May Amplify Glomerular Injury, Journal of the American Society of Nephrology, vol.13, issue.10, pp.2488-96, 2002.
DOI : 10.1097/01.ASN.0000029588.07166.20

X. Lei, Y. Ohkawara, and M. Stampfli, Disruption of antigen-induced inflammatory responses in CD40 ligand knockout mice., Journal of Clinical Investigation, vol.101, issue.6, pp.1342-53, 1998.
DOI : 10.1172/JCI1662

A. May, T. Kalsch, and S. Massberg, Engagement of Glycoprotein IIb/IIIa (alphaIIbbeta3) on Platelets Upregulates CD40L and Triggers CD40L-Dependent Matrix Degradation by Endothelial Cells, Circulation, vol.106, issue.16, pp.2111-2118, 2002.
DOI : 10.1161/01.CIR.0000033597.45947.0F

M. Czapiga, A. Kirk, and J. Lekstrom-himes, Platelets deliver costimulatory signals to antigen-presenting cells: A potential bridge between injury and immune activation, Experimental Hematology, vol.32, issue.2, pp.135-144, 2004.
DOI : 10.1016/j.exphem.2003.11.004

B. Elzey, J. Tian, and R. Jensen, Platelet-Mediated Modulation of Adaptive Immunity, Immunity, vol.19, issue.1, pp.9-19, 2003.
DOI : 10.1016/S1074-7613(03)00177-8

K. Prasad, P. Andre, Y. Yan, and D. Phillips, The platelet CD40L/GP IIb-IIIa axis in atherothrombotic disease, Current Opinion in Hematology, vol.10, issue.5, pp.356-61, 2003.
DOI : 10.1097/00062752-200309000-00006

K. Buchner, V. Henn, and M. Grafe, T cells and platelets: implications for CD40-CD40L signalling in atherosclerosis, The Journal of Pathology, vol.89, issue.2, pp.288-95, 2003.
DOI : 10.1002/path.1425

F. Mach, U. Schonbeck, and G. Sukhova, Reduction of atherosclerosis in mice by inhibition of CD40 signalling, Nature, vol.16, issue.6689, pp.200-203, 1998.
DOI : 10.1038/28204

E. Lutgens, L. Gorelik, and M. Daemen, Requirement for CD154 in the progression of atherosclerosis, Nature Medicine, vol.54, issue.11, pp.1313-1319, 1999.
DOI : 10.1016/S0008-6363(98)00311-3

R. Reul, J. Fang, and M. Denton, CD40 AND CD40 LIGAND (CD154) ARE COEXPRESSED ON MICROVESSELS IN VIVO IN HUMAN CARDIAC ALLOGRAFT REJECTION1,2, Transplantation, vol.64, issue.12, pp.1765-74, 1997.
DOI : 10.1097/00007890-199712270-00025

A. Kirk, D. Harlan, and N. Armstrong, CTLA4-Ig and anti-CD40 ligand prevent renal allograft rejection in primates, Proceedings of the National Academy of Sciences, vol.148, issue.8, pp.8789-94, 1997.
DOI : 10.1016/0198-8859(91)90064-G
URL : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC23132/pdf

K. Tamada, H. Tamura, and D. Flies, Blockade of LIGHT/LT?? and CD40 signaling induces allospecific T cell anergy, preventing graft-versus-host disease, Journal of Clinical Investigation, vol.109, issue.4, pp.549-57, 2002.
DOI : 10.1172/JCI0213604

S. Kalled, A. Cutler, S. Datta, and D. Thomas, Anti-CD40 ligand antibody treatment of snf1 mice with established nephritis: preservation of kidney function, J Immunol, vol.160, pp.2158-65, 1998.

L. Kairaitis, Y. Wang, and L. Zheng, Blockade of CD40-CD40 ligand protects against renal injury in chronic proteinuric renal disease, Kidney International, vol.64, issue.4, pp.1265-72, 2003.
DOI : 10.1046/j.1523-1755.2003.00223.x

A. Ruth, A. Kitching, and T. Semple, Intrinsic Renal Cell Expression of CD40 Directs Th1 Effectors Inducing Experimental Crescentic Glomerulonephritis, Journal of the American Society of Nephrology, vol.14, issue.11, pp.2813-2835, 2003.
DOI : 10.1097/01.ASN.0000091381.60059.FB

M. Yellin, D. Agati, V. Parkinson, and G. , Immunohistologic analysis of renal CD40 and CD40L expression in lupus nephritis and other glomerulonephritides, Arthritis & Rheumatism, vol.156, issue.1, pp.124-158, 1997.
DOI : 10.1002/art.1780400117

Y. Delmas, J. Viallard, and A. Solanilla, Activation of mesangial cells by platelets in systemic lupus erythematosus via a CD154-dependent induction of CD40, Kidney International, vol.68, issue.5, 2005.
DOI : 10.1111/j.1523-1755.2005.00663.x